title: Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry.
abstract: BACKGROUND
  Little information is available regarding the long-term incidence of end-stage renal disease (ESRD) and survival after the introduction of renal replacement therapy (RRT) in patients with type 1 diabetes.
  
  
  METHODS
  We studied 1,075 patients with type 1 diabetes (onset age < 18 years) diagnosed between 1965 and 1979, who comprise the Allegheny County population-based registry. Onset of ESRD was defined as the introduction of RRT (dialysis or transplantation).
  
  
  RESULTS
  Of 1,075 registrants, the living status of 975 patients (90.7%) and complication status of 798 patients (74.2%) were ascertained as of January 1, 1999. During the observation period, 104 patients (13.0%) developed ESRD, for an incidence rate of 521/100,000 person-years (95% confidence interval, 424 to 629). The cumulative incidence of ESRD was 11.3% at 25 years of diabetes. A significant decline was observed in 20-year cumulative incidence rates of ESRD for patients diagnosed between 1965 and 1969, 1970 and 1974, and 1975 and 1979 (9.1%, 4.7%, and 3.6%, respectively; P = 0.006). Of 104 patients with ESRD, 29 patients (28%) received dialysis alone, 44 patients (42%) received dialysis followed by kidney transplantation, 26 patients (25%) underwent successful transplantation alone, and 5 patients (5%) underwent a failed kidney transplantation followed by dialysis therapy. The cumulative survival rate 10 years after the introduction of RRT was 51.2%. The cumulative survival rate of dialysis therapy followed by kidney transplantation was significantly greater than that of dialysis therapy alone (P < 0.001). No difference was detected in survival between pancreas-kidney transplant recipients and kidney-alone transplant recipients (P = 0.7).
  
  
  CONCLUSIONS
  The incidence of ESRD observed in this cohort has declined, probably reflecting the better glycemic and blood pressure control available since the early 1980s.
authors.affiliation: Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. rimei@excite.co.jp
authors.forename: Rimei
authors.initials: R
authors.lastname: Nishimura
authors.forename: Janice S
authors.initials: JS
authors.lastname: Dorman
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Bosnyak
authors.forename: Naoko
authors.initials: N
authors.lastname: Tajima
authors.forename: Dorothy J
authors.initials: DJ
authors.lastname: Becker
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Orchard
mesh_terms: D000293:Adolescent; D002423:Cause of Death; D002648:Child; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000453:epidemiology*; D003928:Diabetic Nephropathies / Q000453:epidemiology / Q000628:therapy; D005260:Female; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000453:epidemiology* / Q000628:therapy; D008297:Male; D009026:Mortality / Q000639:trends; D016035:Pancreas Transplantation / Q000706:statistics & numerical data; D010414:Pennsylvania / Q000453:epidemiology; D016016:Proportional Hazards Models; D017582:Renal Replacement Therapy / Q000706:statistics & numerical data; D012306:Risk; D016019:Survival Analysis